CLINICAL_TRIALS
trial_result
· 2012-08-23
Clinical Trial Update: Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401 [Phase 4]
Summary
Phase 4 extension study of Epoprostenol for Injection in pulmonary arterial hypertension with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2012-08-23